Chapter 1: Overview, Epidemiology, and Pathogenesis of Acute Coronary Syndrome
Adherence to clinical guidelines is becoming ever more critical in health care today. This activity is the first of seven chapters. Chapter One provides an overview of Acute Coronary Syndrome (ACS), as well as discussions on topics relative to epidemiology and pathogenesis of ACS.
View Activity Information

Chapter 1: Overview, Epidemiology, and Pathogenesis of Acute Coronary Syndrome


Participation and Successful Completion
Successful completion of this CE activity includes the following: 

  1. Register and view the course online.
  2. View the content in its entirety.
  3. Complete a post-test with a minimum score of 77%.
  4. Complete a survey of your learning experience.
  5. Claim your CME/CE Certificate.


Hardware/Software Requirements
Internet Explorer 7 or greater, Firefox (Latest Version), Google Chrome, Windows 7 or above, Safari (Latest Version), Adobe Acrobat Reader, Internet Explorer is not supported on the Macintosh, Mac OS 10.4

Target Audience
Physicians
Nurses
Pharmacists
 

Description
Adherence to clinical guidelines is becoming ever more critical in health care today.  Yet the results of numerous studies find that, even today, clinicians often practice outside the parameters of guidelines, in turn, leading to poor outcomes and higher costs of care.  This applies to both preventive care and the treatment of patients with ACS.

This first chapter gives an overview of Acute Coronary Syndrome (ACS), as well as discussions on topics relative to epidemiology and pathogenesis of ACS.  The materials and discussions presented in this first chapter, as well as the chapters that will follow, in this multimedia eBook are derived directly from the American Heart Association/American College of Cardiology (AHA/ACC) 2014 Guidelines on the Management of Patients with Non–ST-Elevation Acute Coronary Syndromes (NTSE-ACS).  As an enhancement to the NSTE-ACS Guidelines, this e-book is designed to explain the evidence behind the ACS guidelines.  The interactive, engaging manner, and flow of this eBook aid in the assimilation of information, further facilitating improved quality of care provided to your patients.

In addition to the practical information found in the 2014 Guidelines, to remain current and up-to-date in this dynamic and evolving area, valuable new material is included throughout the chapters.  Furthermore, the reader will find, contained within these pages, highly detailed, yet concise information relevant to the practice of cardiovascular medicine in today’s value-based reimbursement environment.

Complete table of contents

  • Chapter 1: Overview, Epidemiology, and Pathogenesis of Acute Coronary Syndrome*
  • Chapter 2: Initial Evaluation and Management of NSTE-ACE
  • Chapter 3: Early Hospital Care
  • Chapter 4: Revascularization
  • Chapter 5: Late Hospital Care, Hospital Discharge, and Posthospital Discharge Care
  • Chapter 6: Special Populations
  • Chapter 7: Use of Performance Measures and Registries

*Please note:  this activity includes only Chapter One.
 

Learning Objectives 
At the completion of this online course, the learner will be able to:

  1. Discuss the clinical presentation and classification of ACS
  2. Describe the pathophysiology of ACS
  3. Discuss the epidemiology of ACS in the United States
  4. List the modifiable and nonmodifiable risk factors for ACS
  5. Identify opportunities for primary prevention of ACS


Course Agenda

Presentation

Faculty

Learning Objective

Chapter 1: Overview of ACS (Acute Coronary Syndromes: Overview, Epidemiology, and Pathophysiology)

Hani Jneid

1-5


Estimated Time to Complete the Educational Activity
45 minutes

Faculty
Hani Jneid, MD
Associate Professor
Department of Medicine – Division of Cardiology
Baylor College of Medicine
 

Accreditation Statements

ORIGINAL RELEASE DATE:  01/05/2018

TERMINATION DATE:  01/05/2021

LAST REVIEW DATE: November 2017 

ACCREDITATION TERMS:
Joint Accreditation – 01/05/2018 – 01/05/2021

In support of improving patient care, the American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians
The American Heart Association designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.75 hour of Category I credit for completing this program.

AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 0.50 contact hour.

ACPE Credit Designation Statement – Pharmacists
ACPE Credit: 0.50 Contact Hour Universal Program Number: J0000134-0000-18-004-H04-P

Disclosures
All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.

Faculty Member

Employment

Research Grant

Consultant/
Advisory Board

Stock Shareholder (directly purchased)

Honoraria

Other

Speaker’s Bureau

Hani Jneid

Baylor College of Medicine

None

None

None

None

None

Kiran Musunuru

Harvard University

None

None

None

None

None

Michele Pelter

UCSF School of Nursing

None

None

None

None

None

Barbara Wiggins

Medical University of South Carolina

None

None

None

None

None

Sarah Spinler

University of Pennsylvania

None

None

None

AstraZeneca, Boehringer Ingelheim, Daichi Sankyo

None

Ezra Amsterdam

University of California Davis

None

Astra Zeneca

None

None

None

This table represents the relationships of this educational activity’s faculty members that may be perceived as actual or reasonable perceived conflicts of interest as reported on the Disclosure Questionnaire which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content.


Medium
This activity is an internet-based activity.

Contact Information
To contact the American Heart Association for any questions, please call our customer support center at 888-242-2453.
 

Policy on Privacy and Confidentiality
Please see the privacy link at the bottom of the Professional Education Center.
 

Copyright Information
Please see the link at the bottom of the Professional Education Center.

Commercial Support
This activity for professionals is part of the Guidelines Transformation & Optimization Program and is supported by an educational grant from AstraZeneca.  The American Heart Association’s Guideline Transformation & Optimization (GTO) Program is a comprehensive, coordinated approach to accelerate guidelines into clinical practice.

AstraZeneca is a proud inaugural sponsor of the American Heart Association’s Guideline Transformation & Optimization Initiative.



Type:  Internet Activity (Enduring Material)
FREE
Activity Price
127 Registered Users
Credits
0.75 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit

0.5 Contact Hours> Accreditation Council for Pharmacy Education> ACPE

0 Credits> American Heart Association> AHA

0.5 Contact Hours> American Nurses Credentialing Center> ANCC

0.75 Credits> Accreditation Council for Continuing Medical Education> Attendance Credit